Drugs / Zika Virus Purified Inactivated Vaccine (ZPIV)
last change Dec 2018 re-read 3 minutes ago

Zika Virus Purified Inactivated Vaccine (ZPIV)

Vaccine

Developed for
Zika virus infectious disease
Investigated by
National Institute of Allergy and Infectious Diseases (NIAID)

Trials 1

20172018201920202021202220232024202520262027
PhaseRegistry idDatesIndicationSponsorStatusOutcome
Phase 1 NCT02952833 Oct 2016 → Dec 2018 Zika virus infectious disease National Institute of Allergy and Infectious Diseases (NIAID) Completed No outcome recorded

Evidence & citations 2 cited values

Every value below carries the sentence it was read from. 2 sources stand behind the page.

FieldValueCited text
Known as Zika Virus Purified Inactivated Vaccine (ZPIV) ClinicalTrials.gov intervention name — accepted as the source's own label NCT02952833 ↗
Modality Vaccine “purified formalin-inactivated Zika virus vaccine” PMID 29217375 ↗ Dec 2017